This webinar will look at the principles of the assays available to monitor heparin. The most frequent assay that is used is the activated partial thromboplastin time (aPTT). This assay is readily ...
Baebies Receives FDA Breakthrough Device Designation for First Point-of-Care Heparin Monitoring Test
DURHAM, N.C., April 23, 2025 /PRNewswire/ -- Baebies has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Anti-Factor Xa test on the FINDER® platform ...
There are a number of limitations to the current study. A power calculation was not performed prior to beginning data collection. The decision to include 50 patients in each arm was based on ...
Heparin (ball and stick structure) activates antithrombin-III (gray) to bind to and inhibit thrombin (purple). All this raises the questions: Just what is heparin? Where does it come from? What does ...
Ever since the introduction of the direct oral anticoagulants (DOACs), such as apixaban and rivaroxaban, laboratory staff and clinicians have been confronted with unique challenges in determining ...
Venous thromboembolism (VTE) is common in patients with cancer. Long-term daily subcutaneous low molecular weight heparin has been standard treatment for such patients. The purpose of this study was ...
An automated chromogenic test called the INNOVANCE Anti-Xa assay is used to quantify the levels of rivaroxaban 1, apixaban, and edoxaban 1 in citrated human plasma, as well as the activity of ...
Outcomes of temozolomide and capecitabine chemotherapy used in neuroendocrine and endocrine tumours: A real-world comparison of treatment evidence in Alberta, Canada, from 2011-2021. This is an ASCO ...
A new study has shown that COVID-19 patients admitted to the Intensive care unit may be resistant to the naturally occurring anticoagulant Heparin. The study titled, “Heparin resistance in COVID‑19 ...
Therapeutic-dose heparin appears to benefit noncritically-ill COVID-19 patients, but it does not reduce deaths or other adverse endpoints compared with usual-care thromboprophylaxis if it’s initiated ...
It is not clear whether individuals with severely impaired renal function are more susceptible to bleeding complications of low-molecular-weight heparin (LMWH). Published and unpublished studies in ...
This was a single-center, observational cohort study conducted at an 852-bed academic medical center. The study involved a review of electronic and paper medical records of patients who received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results